Global Oral Medicines for Diabetes Supply, Demand and Key Producers, 2023-2029
The global Oral Medicines for Diabetes market size is expected to reach $ 124450 million by 2029, rising at a market growth of 10.2% CAGR during the forecast period (2023-2029).
Oral medications for diabetes are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report studies the global Oral Medicines for Diabetes production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Medicines for Diabetes, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Medicines for Diabetes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Medicines for Diabetes total production and demand, 2018-2029, (K Units)
Global Oral Medicines for Diabetes total production value, 2018-2029, (USD Million)
Global Oral Medicines for Diabetes production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Medicines for Diabetes consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oral Medicines for Diabetes domestic production, consumption, key domestic manufacturers and share
Global Oral Medicines for Diabetes production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oral Medicines for Diabetes production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Medicines for Diabetes production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oral Medicines for Diabetes market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Medicines for Diabetes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oral Medicines for Diabetes Market, By Region:
1. How big is the global Oral Medicines for Diabetes market?
2. What is the demand of the global Oral Medicines for Diabetes market?
3. What is the year over year growth of the global Oral Medicines for Diabetes market?
4. What is the production and production value of the global Oral Medicines for Diabetes market?
5. Who are the key producers in the global Oral Medicines for Diabetes market?
6. What are the growth factors driving the market demand?
Oral medications for diabetes are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report studies the global Oral Medicines for Diabetes production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Medicines for Diabetes, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Medicines for Diabetes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Medicines for Diabetes total production and demand, 2018-2029, (K Units)
Global Oral Medicines for Diabetes total production value, 2018-2029, (USD Million)
Global Oral Medicines for Diabetes production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Medicines for Diabetes consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oral Medicines for Diabetes domestic production, consumption, key domestic manufacturers and share
Global Oral Medicines for Diabetes production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oral Medicines for Diabetes production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Medicines for Diabetes production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oral Medicines for Diabetes market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Medicines for Diabetes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oral Medicines for Diabetes Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Biguanides
- Sulfonylureas
- Meglitinides
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- SGLT2 Inhibitors
- Thiazolidinediones
- Alpha-Glucosidase Inhibitors
- Other
- Hospital
- Clinic
- Other
- Bayer
- Merck
- Novartis
- Huadong Medicine
- Sanofi
- Novo Nordisk
- Servier
- Takeda Pharmaceutical
- Luye Pharmaceutical
- Taiji Group
- CR Double-Crane
- AstraZeneca
- Boehringer Ingelheim
- Qilu Pharmaceutical
- Jiangsu Deyuan Pharmaceutical
- CTTQ
1. How big is the global Oral Medicines for Diabetes market?
2. What is the demand of the global Oral Medicines for Diabetes market?
3. What is the year over year growth of the global Oral Medicines for Diabetes market?
4. What is the production and production value of the global Oral Medicines for Diabetes market?
5. Who are the key producers in the global Oral Medicines for Diabetes market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oral Medicines for Diabetes Introduction
1.2 World Oral Medicines for Diabetes Supply & Forecast
1.2.1 World Oral Medicines for Diabetes Production Value (2018 & 2022 & 2029)
1.2.2 World Oral Medicines for Diabetes Production (2018-2029)
1.2.3 World Oral Medicines for Diabetes Pricing Trends (2018-2029)
1.3 World Oral Medicines for Diabetes Production by Region (Based on Production Site)
1.3.1 World Oral Medicines for Diabetes Production Value by Region (2018-2029)
1.3.2 World Oral Medicines for Diabetes Production by Region (2018-2029)
1.3.3 World Oral Medicines for Diabetes Average Price by Region (2018-2029)
1.3.4 North America Oral Medicines for Diabetes Production (2018-2029)
1.3.5 Europe Oral Medicines for Diabetes Production (2018-2029)
1.3.6 China Oral Medicines for Diabetes Production (2018-2029)
1.3.7 Japan Oral Medicines for Diabetes Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Medicines for Diabetes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Medicines for Diabetes Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oral Medicines for Diabetes Demand (2018-2029)
2.2 World Oral Medicines for Diabetes Consumption by Region
2.2.1 World Oral Medicines for Diabetes Consumption by Region (2018-2023)
2.2.2 World Oral Medicines for Diabetes Consumption Forecast by Region (2024-2029)
2.3 United States Oral Medicines for Diabetes Consumption (2018-2029)
2.4 China Oral Medicines for Diabetes Consumption (2018-2029)
2.5 Europe Oral Medicines for Diabetes Consumption (2018-2029)
2.6 Japan Oral Medicines for Diabetes Consumption (2018-2029)
2.7 South Korea Oral Medicines for Diabetes Consumption (2018-2029)
2.8 ASEAN Oral Medicines for Diabetes Consumption (2018-2029)
2.9 India Oral Medicines for Diabetes Consumption (2018-2029)
3 WORLD ORAL MEDICINES FOR DIABETES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Medicines for Diabetes Production Value by Manufacturer (2018-2023)
3.2 World Oral Medicines for Diabetes Production by Manufacturer (2018-2023)
3.3 World Oral Medicines for Diabetes Average Price by Manufacturer (2018-2023)
3.4 Oral Medicines for Diabetes Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Medicines for Diabetes Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Medicines for Diabetes in 2022
3.5.3 Global Concentration Ratios (CR8) for Oral Medicines for Diabetes in 2022
3.6 Oral Medicines for Diabetes Market: Overall Company Footprint Analysis
3.6.1 Oral Medicines for Diabetes Market: Region Footprint
3.6.2 Oral Medicines for Diabetes Market: Company Product Type Footprint
3.6.3 Oral Medicines for Diabetes Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Medicines for Diabetes Production Value Comparison
4.1.1 United States VS China: Oral Medicines for Diabetes Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oral Medicines for Diabetes Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oral Medicines for Diabetes Production Comparison
4.2.1 United States VS China: Oral Medicines for Diabetes Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oral Medicines for Diabetes Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oral Medicines for Diabetes Consumption Comparison
4.3.1 United States VS China: Oral Medicines for Diabetes Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oral Medicines for Diabetes Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oral Medicines for Diabetes Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
4.5 China Based Oral Medicines for Diabetes Manufacturers and Market Share
4.5.1 China Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.5.3 China Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
4.6 Rest of World Based Oral Medicines for Diabetes Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Medicines for Diabetes Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biguanides
5.2.2 Sulfonylureas
5.2.3 Meglitinides
5.2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
5.2.5 SGLT2 Inhibitors
5.2.6 Thiazolidinediones
5.2.7 Alpha-Glucosidase Inhibitors
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Oral Medicines for Diabetes Production by Type (2018-2029)
5.3.2 World Oral Medicines for Diabetes Production Value by Type (2018-2029)
5.3.3 World Oral Medicines for Diabetes Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Medicines for Diabetes Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Oral Medicines for Diabetes Production by Application (2018-2029)
6.3.2 World Oral Medicines for Diabetes Production Value by Application (2018-2029)
6.3.3 World Oral Medicines for Diabetes Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Oral Medicines for Diabetes Product and Services
7.1.4 Bayer Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Oral Medicines for Diabetes Product and Services
7.2.4 Merck Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Oral Medicines for Diabetes Product and Services
7.3.4 Novartis Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Huadong Medicine
7.4.1 Huadong Medicine Details
7.4.2 Huadong Medicine Major Business
7.4.3 Huadong Medicine Oral Medicines for Diabetes Product and Services
7.4.4 Huadong Medicine Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Huadong Medicine Recent Developments/Updates
7.4.6 Huadong Medicine Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Oral Medicines for Diabetes Product and Services
7.5.4 Sanofi Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Novo Nordisk
7.6.1 Novo Nordisk Details
7.6.2 Novo Nordisk Major Business
7.6.3 Novo Nordisk Oral Medicines for Diabetes Product and Services
7.6.4 Novo Nordisk Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novo Nordisk Recent Developments/Updates
7.6.6 Novo Nordisk Competitive Strengths & Weaknesses
7.7 Servier
7.7.1 Servier Details
7.7.2 Servier Major Business
7.7.3 Servier Oral Medicines for Diabetes Product and Services
7.7.4 Servier Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Servier Recent Developments/Updates
7.7.6 Servier Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Details
7.8.2 Takeda Pharmaceutical Major Business
7.8.3 Takeda Pharmaceutical Oral Medicines for Diabetes Product and Services
7.8.4 Takeda Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.9 Luye Pharmaceutical
7.9.1 Luye Pharmaceutical Details
7.9.2 Luye Pharmaceutical Major Business
7.9.3 Luye Pharmaceutical Oral Medicines for Diabetes Product and Services
7.9.4 Luye Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Luye Pharmaceutical Recent Developments/Updates
7.9.6 Luye Pharmaceutical Competitive Strengths & Weaknesses
7.10 Taiji Group
7.10.1 Taiji Group Details
7.10.2 Taiji Group Major Business
7.10.3 Taiji Group Oral Medicines for Diabetes Product and Services
7.10.4 Taiji Group Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Taiji Group Recent Developments/Updates
7.10.6 Taiji Group Competitive Strengths & Weaknesses
7.11 CR Double-Crane
7.11.1 CR Double-Crane Details
7.11.2 CR Double-Crane Major Business
7.11.3 CR Double-Crane Oral Medicines for Diabetes Product and Services
7.11.4 CR Double-Crane Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CR Double-Crane Recent Developments/Updates
7.11.6 CR Double-Crane Competitive Strengths & Weaknesses
7.12 AstraZeneca
7.12.1 AstraZeneca Details
7.12.2 AstraZeneca Major Business
7.12.3 AstraZeneca Oral Medicines for Diabetes Product and Services
7.12.4 AstraZeneca Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 AstraZeneca Recent Developments/Updates
7.12.6 AstraZeneca Competitive Strengths & Weaknesses
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Details
7.13.2 Boehringer Ingelheim Major Business
7.13.3 Boehringer Ingelheim Oral Medicines for Diabetes Product and Services
7.13.4 Boehringer Ingelheim Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Boehringer Ingelheim Recent Developments/Updates
7.13.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.14 Qilu Pharmaceutical
7.14.1 Qilu Pharmaceutical Details
7.14.2 Qilu Pharmaceutical Major Business
7.14.3 Qilu Pharmaceutical Oral Medicines for Diabetes Product and Services
7.14.4 Qilu Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qilu Pharmaceutical Recent Developments/Updates
7.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.15 Jiangsu Deyuan Pharmaceutical
7.15.1 Jiangsu Deyuan Pharmaceutical Details
7.15.2 Jiangsu Deyuan Pharmaceutical Major Business
7.15.3 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product and Services
7.15.4 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
7.15.6 Jiangsu Deyuan Pharmaceutical Competitive Strengths & Weaknesses
7.16 CTTQ
7.16.1 CTTQ Details
7.16.2 CTTQ Major Business
7.16.3 CTTQ Oral Medicines for Diabetes Product and Services
7.16.4 CTTQ Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 CTTQ Recent Developments/Updates
7.16.6 CTTQ Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral Medicines for Diabetes Industry Chain
8.2 Oral Medicines for Diabetes Upstream Analysis
8.2.1 Oral Medicines for Diabetes Core Raw Materials
8.2.2 Main Manufacturers of Oral Medicines for Diabetes Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Medicines for Diabetes Production Mode
8.6 Oral Medicines for Diabetes Procurement Model
8.7 Oral Medicines for Diabetes Industry Sales Model and Sales Channels
8.7.1 Oral Medicines for Diabetes Sales Model
8.7.2 Oral Medicines for Diabetes Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oral Medicines for Diabetes Introduction
1.2 World Oral Medicines for Diabetes Supply & Forecast
1.2.1 World Oral Medicines for Diabetes Production Value (2018 & 2022 & 2029)
1.2.2 World Oral Medicines for Diabetes Production (2018-2029)
1.2.3 World Oral Medicines for Diabetes Pricing Trends (2018-2029)
1.3 World Oral Medicines for Diabetes Production by Region (Based on Production Site)
1.3.1 World Oral Medicines for Diabetes Production Value by Region (2018-2029)
1.3.2 World Oral Medicines for Diabetes Production by Region (2018-2029)
1.3.3 World Oral Medicines for Diabetes Average Price by Region (2018-2029)
1.3.4 North America Oral Medicines for Diabetes Production (2018-2029)
1.3.5 Europe Oral Medicines for Diabetes Production (2018-2029)
1.3.6 China Oral Medicines for Diabetes Production (2018-2029)
1.3.7 Japan Oral Medicines for Diabetes Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Medicines for Diabetes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Medicines for Diabetes Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oral Medicines for Diabetes Demand (2018-2029)
2.2 World Oral Medicines for Diabetes Consumption by Region
2.2.1 World Oral Medicines for Diabetes Consumption by Region (2018-2023)
2.2.2 World Oral Medicines for Diabetes Consumption Forecast by Region (2024-2029)
2.3 United States Oral Medicines for Diabetes Consumption (2018-2029)
2.4 China Oral Medicines for Diabetes Consumption (2018-2029)
2.5 Europe Oral Medicines for Diabetes Consumption (2018-2029)
2.6 Japan Oral Medicines for Diabetes Consumption (2018-2029)
2.7 South Korea Oral Medicines for Diabetes Consumption (2018-2029)
2.8 ASEAN Oral Medicines for Diabetes Consumption (2018-2029)
2.9 India Oral Medicines for Diabetes Consumption (2018-2029)
3 WORLD ORAL MEDICINES FOR DIABETES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Medicines for Diabetes Production Value by Manufacturer (2018-2023)
3.2 World Oral Medicines for Diabetes Production by Manufacturer (2018-2023)
3.3 World Oral Medicines for Diabetes Average Price by Manufacturer (2018-2023)
3.4 Oral Medicines for Diabetes Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Medicines for Diabetes Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Medicines for Diabetes in 2022
3.5.3 Global Concentration Ratios (CR8) for Oral Medicines for Diabetes in 2022
3.6 Oral Medicines for Diabetes Market: Overall Company Footprint Analysis
3.6.1 Oral Medicines for Diabetes Market: Region Footprint
3.6.2 Oral Medicines for Diabetes Market: Company Product Type Footprint
3.6.3 Oral Medicines for Diabetes Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Medicines for Diabetes Production Value Comparison
4.1.1 United States VS China: Oral Medicines for Diabetes Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oral Medicines for Diabetes Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oral Medicines for Diabetes Production Comparison
4.2.1 United States VS China: Oral Medicines for Diabetes Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oral Medicines for Diabetes Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oral Medicines for Diabetes Consumption Comparison
4.3.1 United States VS China: Oral Medicines for Diabetes Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oral Medicines for Diabetes Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oral Medicines for Diabetes Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
4.5 China Based Oral Medicines for Diabetes Manufacturers and Market Share
4.5.1 China Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.5.3 China Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
4.6 Rest of World Based Oral Medicines for Diabetes Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oral Medicines for Diabetes Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Medicines for Diabetes Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biguanides
5.2.2 Sulfonylureas
5.2.3 Meglitinides
5.2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
5.2.5 SGLT2 Inhibitors
5.2.6 Thiazolidinediones
5.2.7 Alpha-Glucosidase Inhibitors
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Oral Medicines for Diabetes Production by Type (2018-2029)
5.3.2 World Oral Medicines for Diabetes Production Value by Type (2018-2029)
5.3.3 World Oral Medicines for Diabetes Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Medicines for Diabetes Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Oral Medicines for Diabetes Production by Application (2018-2029)
6.3.2 World Oral Medicines for Diabetes Production Value by Application (2018-2029)
6.3.3 World Oral Medicines for Diabetes Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Oral Medicines for Diabetes Product and Services
7.1.4 Bayer Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Oral Medicines for Diabetes Product and Services
7.2.4 Merck Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Oral Medicines for Diabetes Product and Services
7.3.4 Novartis Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Huadong Medicine
7.4.1 Huadong Medicine Details
7.4.2 Huadong Medicine Major Business
7.4.3 Huadong Medicine Oral Medicines for Diabetes Product and Services
7.4.4 Huadong Medicine Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Huadong Medicine Recent Developments/Updates
7.4.6 Huadong Medicine Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Oral Medicines for Diabetes Product and Services
7.5.4 Sanofi Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Novo Nordisk
7.6.1 Novo Nordisk Details
7.6.2 Novo Nordisk Major Business
7.6.3 Novo Nordisk Oral Medicines for Diabetes Product and Services
7.6.4 Novo Nordisk Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novo Nordisk Recent Developments/Updates
7.6.6 Novo Nordisk Competitive Strengths & Weaknesses
7.7 Servier
7.7.1 Servier Details
7.7.2 Servier Major Business
7.7.3 Servier Oral Medicines for Diabetes Product and Services
7.7.4 Servier Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Servier Recent Developments/Updates
7.7.6 Servier Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Details
7.8.2 Takeda Pharmaceutical Major Business
7.8.3 Takeda Pharmaceutical Oral Medicines for Diabetes Product and Services
7.8.4 Takeda Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.9 Luye Pharmaceutical
7.9.1 Luye Pharmaceutical Details
7.9.2 Luye Pharmaceutical Major Business
7.9.3 Luye Pharmaceutical Oral Medicines for Diabetes Product and Services
7.9.4 Luye Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Luye Pharmaceutical Recent Developments/Updates
7.9.6 Luye Pharmaceutical Competitive Strengths & Weaknesses
7.10 Taiji Group
7.10.1 Taiji Group Details
7.10.2 Taiji Group Major Business
7.10.3 Taiji Group Oral Medicines for Diabetes Product and Services
7.10.4 Taiji Group Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Taiji Group Recent Developments/Updates
7.10.6 Taiji Group Competitive Strengths & Weaknesses
7.11 CR Double-Crane
7.11.1 CR Double-Crane Details
7.11.2 CR Double-Crane Major Business
7.11.3 CR Double-Crane Oral Medicines for Diabetes Product and Services
7.11.4 CR Double-Crane Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CR Double-Crane Recent Developments/Updates
7.11.6 CR Double-Crane Competitive Strengths & Weaknesses
7.12 AstraZeneca
7.12.1 AstraZeneca Details
7.12.2 AstraZeneca Major Business
7.12.3 AstraZeneca Oral Medicines for Diabetes Product and Services
7.12.4 AstraZeneca Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 AstraZeneca Recent Developments/Updates
7.12.6 AstraZeneca Competitive Strengths & Weaknesses
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Details
7.13.2 Boehringer Ingelheim Major Business
7.13.3 Boehringer Ingelheim Oral Medicines for Diabetes Product and Services
7.13.4 Boehringer Ingelheim Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Boehringer Ingelheim Recent Developments/Updates
7.13.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.14 Qilu Pharmaceutical
7.14.1 Qilu Pharmaceutical Details
7.14.2 Qilu Pharmaceutical Major Business
7.14.3 Qilu Pharmaceutical Oral Medicines for Diabetes Product and Services
7.14.4 Qilu Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qilu Pharmaceutical Recent Developments/Updates
7.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.15 Jiangsu Deyuan Pharmaceutical
7.15.1 Jiangsu Deyuan Pharmaceutical Details
7.15.2 Jiangsu Deyuan Pharmaceutical Major Business
7.15.3 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product and Services
7.15.4 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
7.15.6 Jiangsu Deyuan Pharmaceutical Competitive Strengths & Weaknesses
7.16 CTTQ
7.16.1 CTTQ Details
7.16.2 CTTQ Major Business
7.16.3 CTTQ Oral Medicines for Diabetes Product and Services
7.16.4 CTTQ Oral Medicines for Diabetes Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 CTTQ Recent Developments/Updates
7.16.6 CTTQ Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral Medicines for Diabetes Industry Chain
8.2 Oral Medicines for Diabetes Upstream Analysis
8.2.1 Oral Medicines for Diabetes Core Raw Materials
8.2.2 Main Manufacturers of Oral Medicines for Diabetes Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Medicines for Diabetes Production Mode
8.6 Oral Medicines for Diabetes Procurement Model
8.7 Oral Medicines for Diabetes Industry Sales Model and Sales Channels
8.7.1 Oral Medicines for Diabetes Sales Model
8.7.2 Oral Medicines for Diabetes Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oral Medicines for Diabetes Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oral Medicines for Diabetes Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oral Medicines for Diabetes Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oral Medicines for Diabetes Production Value Market Share by Region (2018-2023)
Table 5. World Oral Medicines for Diabetes Production Value Market Share by Region (2024-2029)
Table 6. World Oral Medicines for Diabetes Production by Region (2018-2023) & (K Units)
Table 7. World Oral Medicines for Diabetes Production by Region (2024-2029) & (K Units)
Table 8. World Oral Medicines for Diabetes Production Market Share by Region (2018-2023)
Table 9. World Oral Medicines for Diabetes Production Market Share by Region (2024-2029)
Table 10. World Oral Medicines for Diabetes Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oral Medicines for Diabetes Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oral Medicines for Diabetes Major Market Trends
Table 13. World Oral Medicines for Diabetes Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oral Medicines for Diabetes Consumption by Region (2018-2023) & (K Units)
Table 15. World Oral Medicines for Diabetes Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oral Medicines for Diabetes Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oral Medicines for Diabetes Producers in 2022
Table 18. World Oral Medicines for Diabetes Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oral Medicines for Diabetes Producers in 2022
Table 20. World Oral Medicines for Diabetes Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oral Medicines for Diabetes Company Evaluation Quadrant
Table 22. World Oral Medicines for Diabetes Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oral Medicines for Diabetes Production Site of Key Manufacturer
Table 24. Oral Medicines for Diabetes Market: Company Product Type Footprint
Table 25. Oral Medicines for Diabetes Market: Company Product Application Footprint
Table 26. Oral Medicines for Diabetes Competitive Factors
Table 27. Oral Medicines for Diabetes New Entrant and Capacity Expansion Plans
Table 28. Oral Medicines for Diabetes Mergers & Acquisitions Activity
Table 29. United States VS China Oral Medicines for Diabetes Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oral Medicines for Diabetes Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oral Medicines for Diabetes Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 37. China Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 42. Rest of World Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 47. World Oral Medicines for Diabetes Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oral Medicines for Diabetes Production by Type (2018-2023) & (K Units)
Table 49. World Oral Medicines for Diabetes Production by Type (2024-2029) & (K Units)
Table 50. World Oral Medicines for Diabetes Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oral Medicines for Diabetes Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oral Medicines for Diabetes Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oral Medicines for Diabetes Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oral Medicines for Diabetes Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oral Medicines for Diabetes Production by Application (2018-2023) & (K Units)
Table 56. World Oral Medicines for Diabetes Production by Application (2024-2029) & (K Units)
Table 57. World Oral Medicines for Diabetes Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oral Medicines for Diabetes Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oral Medicines for Diabetes Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oral Medicines for Diabetes Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Oral Medicines for Diabetes Product and Services
Table 64. Bayer Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Oral Medicines for Diabetes Product and Services
Table 70. Merck Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Oral Medicines for Diabetes Product and Services
Table 76. Novartis Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 80. Huadong Medicine Major Business
Table 81. Huadong Medicine Oral Medicines for Diabetes Product and Services
Table 82. Huadong Medicine Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Huadong Medicine Recent Developments/Updates
Table 84. Huadong Medicine Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Oral Medicines for Diabetes Product and Services
Table 88. Sanofi Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 92. Novo Nordisk Major Business
Table 93. Novo Nordisk Oral Medicines for Diabetes Product and Services
Table 94. Novo Nordisk Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novo Nordisk Recent Developments/Updates
Table 96. Novo Nordisk Competitive Strengths & Weaknesses
Table 97. Servier Basic Information, Manufacturing Base and Competitors
Table 98. Servier Major Business
Table 99. Servier Oral Medicines for Diabetes Product and Services
Table 100. Servier Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Servier Recent Developments/Updates
Table 102. Servier Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Major Business
Table 105. Takeda Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 106. Takeda Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Recent Developments/Updates
Table 108. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Luye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Luye Pharmaceutical Major Business
Table 111. Luye Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 112. Luye Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Luye Pharmaceutical Recent Developments/Updates
Table 114. Luye Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Taiji Group Basic Information, Manufacturing Base and Competitors
Table 116. Taiji Group Major Business
Table 117. Taiji Group Oral Medicines for Diabetes Product and Services
Table 118. Taiji Group Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Taiji Group Recent Developments/Updates
Table 120. Taiji Group Competitive Strengths & Weaknesses
Table 121. CR Double-Crane Basic Information, Manufacturing Base and Competitors
Table 122. CR Double-Crane Major Business
Table 123. CR Double-Crane Oral Medicines for Diabetes Product and Services
Table 124. CR Double-Crane Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CR Double-Crane Recent Developments/Updates
Table 126. CR Double-Crane Competitive Strengths & Weaknesses
Table 127. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 128. AstraZeneca Major Business
Table 129. AstraZeneca Oral Medicines for Diabetes Product and Services
Table 130. AstraZeneca Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. AstraZeneca Recent Developments/Updates
Table 132. AstraZeneca Competitive Strengths & Weaknesses
Table 133. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 134. Boehringer Ingelheim Major Business
Table 135. Boehringer Ingelheim Oral Medicines for Diabetes Product and Services
Table 136. Boehringer Ingelheim Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 139. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Qilu Pharmaceutical Major Business
Table 141. Qilu Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 142. Qilu Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Qilu Pharmaceutical Recent Developments/Updates
Table 144. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Jiangsu Deyuan Pharmaceutical Major Business
Table 147. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 148. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 150. CTTQ Basic Information, Manufacturing Base and Competitors
Table 151. CTTQ Major Business
Table 152. CTTQ Oral Medicines for Diabetes Product and Services
Table 153. CTTQ Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Oral Medicines for Diabetes Upstream (Raw Materials)
Table 155. Oral Medicines for Diabetes Typical Customers
Table 156. Oral Medicines for Diabetes Typical Distributors
Table 1. World Oral Medicines for Diabetes Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oral Medicines for Diabetes Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oral Medicines for Diabetes Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oral Medicines for Diabetes Production Value Market Share by Region (2018-2023)
Table 5. World Oral Medicines for Diabetes Production Value Market Share by Region (2024-2029)
Table 6. World Oral Medicines for Diabetes Production by Region (2018-2023) & (K Units)
Table 7. World Oral Medicines for Diabetes Production by Region (2024-2029) & (K Units)
Table 8. World Oral Medicines for Diabetes Production Market Share by Region (2018-2023)
Table 9. World Oral Medicines for Diabetes Production Market Share by Region (2024-2029)
Table 10. World Oral Medicines for Diabetes Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oral Medicines for Diabetes Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oral Medicines for Diabetes Major Market Trends
Table 13. World Oral Medicines for Diabetes Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oral Medicines for Diabetes Consumption by Region (2018-2023) & (K Units)
Table 15. World Oral Medicines for Diabetes Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oral Medicines for Diabetes Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oral Medicines for Diabetes Producers in 2022
Table 18. World Oral Medicines for Diabetes Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oral Medicines for Diabetes Producers in 2022
Table 20. World Oral Medicines for Diabetes Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oral Medicines for Diabetes Company Evaluation Quadrant
Table 22. World Oral Medicines for Diabetes Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oral Medicines for Diabetes Production Site of Key Manufacturer
Table 24. Oral Medicines for Diabetes Market: Company Product Type Footprint
Table 25. Oral Medicines for Diabetes Market: Company Product Application Footprint
Table 26. Oral Medicines for Diabetes Competitive Factors
Table 27. Oral Medicines for Diabetes New Entrant and Capacity Expansion Plans
Table 28. Oral Medicines for Diabetes Mergers & Acquisitions Activity
Table 29. United States VS China Oral Medicines for Diabetes Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oral Medicines for Diabetes Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oral Medicines for Diabetes Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 37. China Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 42. Rest of World Based Oral Medicines for Diabetes Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oral Medicines for Diabetes Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Market Share (2018-2023)
Table 47. World Oral Medicines for Diabetes Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oral Medicines for Diabetes Production by Type (2018-2023) & (K Units)
Table 49. World Oral Medicines for Diabetes Production by Type (2024-2029) & (K Units)
Table 50. World Oral Medicines for Diabetes Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oral Medicines for Diabetes Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oral Medicines for Diabetes Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oral Medicines for Diabetes Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oral Medicines for Diabetes Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oral Medicines for Diabetes Production by Application (2018-2023) & (K Units)
Table 56. World Oral Medicines for Diabetes Production by Application (2024-2029) & (K Units)
Table 57. World Oral Medicines for Diabetes Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oral Medicines for Diabetes Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oral Medicines for Diabetes Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oral Medicines for Diabetes Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Oral Medicines for Diabetes Product and Services
Table 64. Bayer Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Oral Medicines for Diabetes Product and Services
Table 70. Merck Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Oral Medicines for Diabetes Product and Services
Table 76. Novartis Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 80. Huadong Medicine Major Business
Table 81. Huadong Medicine Oral Medicines for Diabetes Product and Services
Table 82. Huadong Medicine Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Huadong Medicine Recent Developments/Updates
Table 84. Huadong Medicine Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Oral Medicines for Diabetes Product and Services
Table 88. Sanofi Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 92. Novo Nordisk Major Business
Table 93. Novo Nordisk Oral Medicines for Diabetes Product and Services
Table 94. Novo Nordisk Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novo Nordisk Recent Developments/Updates
Table 96. Novo Nordisk Competitive Strengths & Weaknesses
Table 97. Servier Basic Information, Manufacturing Base and Competitors
Table 98. Servier Major Business
Table 99. Servier Oral Medicines for Diabetes Product and Services
Table 100. Servier Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Servier Recent Developments/Updates
Table 102. Servier Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Major Business
Table 105. Takeda Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 106. Takeda Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Recent Developments/Updates
Table 108. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Luye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Luye Pharmaceutical Major Business
Table 111. Luye Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 112. Luye Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Luye Pharmaceutical Recent Developments/Updates
Table 114. Luye Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Taiji Group Basic Information, Manufacturing Base and Competitors
Table 116. Taiji Group Major Business
Table 117. Taiji Group Oral Medicines for Diabetes Product and Services
Table 118. Taiji Group Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Taiji Group Recent Developments/Updates
Table 120. Taiji Group Competitive Strengths & Weaknesses
Table 121. CR Double-Crane Basic Information, Manufacturing Base and Competitors
Table 122. CR Double-Crane Major Business
Table 123. CR Double-Crane Oral Medicines for Diabetes Product and Services
Table 124. CR Double-Crane Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CR Double-Crane Recent Developments/Updates
Table 126. CR Double-Crane Competitive Strengths & Weaknesses
Table 127. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 128. AstraZeneca Major Business
Table 129. AstraZeneca Oral Medicines for Diabetes Product and Services
Table 130. AstraZeneca Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. AstraZeneca Recent Developments/Updates
Table 132. AstraZeneca Competitive Strengths & Weaknesses
Table 133. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 134. Boehringer Ingelheim Major Business
Table 135. Boehringer Ingelheim Oral Medicines for Diabetes Product and Services
Table 136. Boehringer Ingelheim Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 139. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Qilu Pharmaceutical Major Business
Table 141. Qilu Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 142. Qilu Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Qilu Pharmaceutical Recent Developments/Updates
Table 144. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Jiangsu Deyuan Pharmaceutical Major Business
Table 147. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product and Services
Table 148. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 150. CTTQ Basic Information, Manufacturing Base and Competitors
Table 151. CTTQ Major Business
Table 152. CTTQ Oral Medicines for Diabetes Product and Services
Table 153. CTTQ Oral Medicines for Diabetes Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Oral Medicines for Diabetes Upstream (Raw Materials)
Table 155. Oral Medicines for Diabetes Typical Customers
Table 156. Oral Medicines for Diabetes Typical Distributors
LIST OF FIGURES
Figure 1. Oral Medicines for Diabetes Picture
Figure 2. World Oral Medicines for Diabetes Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oral Medicines for Diabetes Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 5. World Oral Medicines for Diabetes Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oral Medicines for Diabetes Production Value Market Share by Region (2018-2029)
Figure 7. World Oral Medicines for Diabetes Production Market Share by Region (2018-2029)
Figure 8. North America Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 9. Europe Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 10. China Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 11. Japan Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 12. Oral Medicines for Diabetes Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 15. World Oral Medicines for Diabetes Consumption Market Share by Region (2018-2029)
Figure 16. United States Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 17. China Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 18. Europe Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 19. Japan Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 22. India Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oral Medicines for Diabetes by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Medicines for Diabetes Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Medicines for Diabetes Markets in 2022
Figure 26. United States VS China: Oral Medicines for Diabetes Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oral Medicines for Diabetes Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oral Medicines for Diabetes Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 30. China Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 32. World Oral Medicines for Diabetes Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oral Medicines for Diabetes Production Value Market Share by Type in 2022
Figure 34. Biguanides
Figure 35. Sulfonylureas
Figure 36. Meglitinides
Figure 37. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 38. SGLT2 Inhibitors
Figure 39. Thiazolidinediones
Figure 40. Alpha-Glucosidase Inhibitors
Figure 41. Other
Figure 42. World Oral Medicines for Diabetes Production Market Share by Type (2018-2029)
Figure 43. World Oral Medicines for Diabetes Production Value Market Share by Type (2018-2029)
Figure 44. World Oral Medicines for Diabetes Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Oral Medicines for Diabetes Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Oral Medicines for Diabetes Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Clinic
Figure 49. Other
Figure 50. World Oral Medicines for Diabetes Production Market Share by Application (2018-2029)
Figure 51. World Oral Medicines for Diabetes Production Value Market Share by Application (2018-2029)
Figure 52. World Oral Medicines for Diabetes Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Oral Medicines for Diabetes Industry Chain
Figure 54. Oral Medicines for Diabetes Procurement Model
Figure 55. Oral Medicines for Diabetes Sales Model
Figure 56. Oral Medicines for Diabetes Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Oral Medicines for Diabetes Picture
Figure 2. World Oral Medicines for Diabetes Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oral Medicines for Diabetes Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 5. World Oral Medicines for Diabetes Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oral Medicines for Diabetes Production Value Market Share by Region (2018-2029)
Figure 7. World Oral Medicines for Diabetes Production Market Share by Region (2018-2029)
Figure 8. North America Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 9. Europe Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 10. China Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 11. Japan Oral Medicines for Diabetes Production (2018-2029) & (K Units)
Figure 12. Oral Medicines for Diabetes Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 15. World Oral Medicines for Diabetes Consumption Market Share by Region (2018-2029)
Figure 16. United States Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 17. China Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 18. Europe Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 19. Japan Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 22. India Oral Medicines for Diabetes Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oral Medicines for Diabetes by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Medicines for Diabetes Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Medicines for Diabetes Markets in 2022
Figure 26. United States VS China: Oral Medicines for Diabetes Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oral Medicines for Diabetes Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oral Medicines for Diabetes Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 30. China Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oral Medicines for Diabetes Production Market Share 2022
Figure 32. World Oral Medicines for Diabetes Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oral Medicines for Diabetes Production Value Market Share by Type in 2022
Figure 34. Biguanides
Figure 35. Sulfonylureas
Figure 36. Meglitinides
Figure 37. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 38. SGLT2 Inhibitors
Figure 39. Thiazolidinediones
Figure 40. Alpha-Glucosidase Inhibitors
Figure 41. Other
Figure 42. World Oral Medicines for Diabetes Production Market Share by Type (2018-2029)
Figure 43. World Oral Medicines for Diabetes Production Value Market Share by Type (2018-2029)
Figure 44. World Oral Medicines for Diabetes Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Oral Medicines for Diabetes Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Oral Medicines for Diabetes Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Clinic
Figure 49. Other
Figure 50. World Oral Medicines for Diabetes Production Market Share by Application (2018-2029)
Figure 51. World Oral Medicines for Diabetes Production Value Market Share by Application (2018-2029)
Figure 52. World Oral Medicines for Diabetes Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Oral Medicines for Diabetes Industry Chain
Figure 54. Oral Medicines for Diabetes Procurement Model
Figure 55. Oral Medicines for Diabetes Sales Model
Figure 56. Oral Medicines for Diabetes Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
